Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Heitz

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Onkologie|August 8, 2013
Fertility-sparing surgery in ovarian cancer: a systematic reviewAndreas du Bois, Florian Heitz, Philipp Harter
Current Oncology Reports|August 25, 2012
Surgery for relapsed ovarian cancer: when should it be offered?Philipp Harter, Florian Heitz, Andreas du Bois
Deutsches Arzteblatt International|May 7, 2026
Ocular Side Effects of Antibody-Drug Conjugates for Cancer TreatmentFlorian Heitz, Andreas Scheider, Philipp Harter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 28, 2014
The sandwich technique of diaphragmatic stripping or full-thickness resection for advanced ovarian cancer: how to keep it short and simpleChristoph Grimm, Philipp Harter, Florian Heitz, et al.
Expert Review of Anticancer Therapy|December 18, 2009
Systemic therapy in recurrent ovarian cancer: current treatment options and new drugsPhilipp Harter, Felix Hilpert, Sven Mahner, et al.
Archives of Gynecology and Obstetrics|February 18, 2014
Implementation of robot-assisted gynecologic surgery for patients with low and high BMI in a German gynecological cancer centerPäivi Kannisto, Philipp Harter, Florian Heitz, et al.
Expert Review of Anticancer Therapy|July 11, 2009
Role of cytoreductive surgery in recurrent ovarian cancerPhilipp Harter, Felix Hilpert, Sven Mahner, et al.
Expert Review of Anticancer Therapy|July 22, 2010
Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapyFlorian Heitz, Philipp Harter, Nina Ewald-Riegler, et al.
Gynecologic Oncology Reports|February 16, 2022
Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experienceMalak Moubarak, Philipp Harter, Beyhan Ataseven, et al.
Therapeutic Advances in Medical Oncology|January 2, 2014
Current and future options in the management and treatment of uterine sarcomaKhalid El-Khalfaoui, Andreas du Bois, Florian Heitz, et al.
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Onkologie|August 8, 2013
Fertility-sparing surgery in ovarian cancer: a systematic reviewAndreas du Bois, Florian Heitz, Philipp Harter
Current Oncology Reports|August 25, 2012
Surgery for relapsed ovarian cancer: when should it be offered?Philipp Harter, Florian Heitz, Andreas du Bois
Deutsches Arzteblatt International|May 7, 2026
Ocular Side Effects of Antibody-Drug Conjugates for Cancer TreatmentFlorian Heitz, Andreas Scheider, Philipp Harter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 28, 2014
The sandwich technique of diaphragmatic stripping or full-thickness resection for advanced ovarian cancer: how to keep it short and simpleChristoph Grimm, Philipp Harter, Florian Heitz, et al.
Expert Review of Anticancer Therapy|December 18, 2009
Systemic therapy in recurrent ovarian cancer: current treatment options and new drugsPhilipp Harter, Felix Hilpert, Sven Mahner, et al.
Archives of Gynecology and Obstetrics|February 18, 2014
Implementation of robot-assisted gynecologic surgery for patients with low and high BMI in a German gynecological cancer centerPäivi Kannisto, Philipp Harter, Florian Heitz, et al.
Expert Review of Anticancer Therapy|July 11, 2009
Role of cytoreductive surgery in recurrent ovarian cancerPhilipp Harter, Felix Hilpert, Sven Mahner, et al.
Expert Review of Anticancer Therapy|July 22, 2010
Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapyFlorian Heitz, Philipp Harter, Nina Ewald-Riegler, et al.
Gynecologic Oncology Reports|February 16, 2022
Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experienceMalak Moubarak, Philipp Harter, Beyhan Ataseven, et al.
Therapeutic Advances in Medical Oncology|January 2, 2014
Current and future options in the management and treatment of uterine sarcomaKhalid El-Khalfaoui, Andreas du Bois, Florian Heitz, et al.
Pageof 18